Binaytara's 2026 National Summit on Hematologic Cancers introduces the "Gray Zone" format and $250K research funding for early-career investigators. Learn more at https://binaytara.org/projects/conferences/2026-national-summit-on-hematologic-cancers
Binaytara's 2026 National Summit on Hematologic Cancers returns to Nashville with a unique "Gray Zone" format, designed to tackle the most challenging clinical questions in hematology. This year's summit, themed "Defining the Standard Where the Guidelines End," will take place from October 16-17 at Music City Center and is expected to attract leading experts and researchers from around the world.
The centerpiece of this event is the "Gray Zone" format, which features case-based sessions centered on real-world hematology cases in leukemia, lymphoma, multiple myeloma, MPN/CML, and CLL. These cases unfold in clinical layers, allowing expert panelists to engage in open, unscripted deliberation that mirrors how clinicians reason when evidence is limited or conflicting.
Dr. Binay Shah, Conference Director and President of Binaytara, emphasizes the Summit's goal: "We are not trying to manufacture consensus on stage. We are trying to model the actual reasoning process specialists use when the data runs out. That is what clinicians tell us they need most — and it's the one thing most conferences are too didactic to show them."
After each session, the deliberations are recorded, transcribed, and developed into expert consensus position statements published in the International Journal of Cancer Care and Delivery (IJCCD). This process extends the Summit's reach far beyond two days in Tennessee, providing clinicians with citable clinical guidance.
In addition to its groundbreaking "Gray Zone" format, the summit includes Binaytara's signature Impact Pitch: Research Award Challenge. This event offers early-career investigators a unique opportunity to present their original hematology project proposals and compete for up to $250,000 in research funding. The program is open to faculty within ten years of fellowship completion and current fellows in hematology and oncology.
The multi-stage process — abstract submission, peer-reviewed proposal evaluation, poster presentation, and the live Impact Pitch — not only funds research but also builds mentorship pathways and amplifies emerging voices in hematologic cancer. Abstract submissions are now open with a deadline of August 15, 2026. Accepted abstracts will be published in the IJCCD.
The summit's program tackles some of the most consequential frontiers in contemporary hematologic oncology. Sessions examine artificial intelligence in hematopathology and measurable residual disease (MRD) assessment, the biology of CAR-T failure and antigen escape, post-CAR-T treatment strategies including bispecific antibodies and next-generation cellular therapies, and MRD as a dynamic decision engine across AML, ALL, multiple myeloma, and CLL.
A dedicated plenary session looks ahead to the 2030 landscape: AI in drug development, decentralized trial infrastructure, and the future of clinical judgment in hematology. The program also confronts the access crisis in cellular therapy head-on — examining the geography of treatment deserts, financial toxicity, payer dynamics, and community-academic partnership models that are beginning to move the needle.
Conference Leadership The Summit is chaired by Dr. Hetty Carraway from Cleveland Clinic, Dr. Nitin Jain from MD Anderson Cancer Center, Shaji Kumar from Mayo Clinic, and Navneet Majhail from Sarah Cannon Cancer Network. The Scientific Review Committee includes leading experts such as Jorge Cortes, Vinod Pullarkat, Martha Mims, Parameswaran Venugopal, and Jerald Radich.
Key Dates
Abstract submission deadline: August 15, 2026
Research Poster presentations: October 16, 2026
Impact Pitch session: October 17, 2026
Conference: October 16-17, 2026
For more information and to submit an abstract, visit the conference website at https://binaytara.org/projects/conferences/2026-national-summit-on-hematologic-cancers or contact the organizers directly.
